FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, specifically to oncology. The method for combined treatment of operable stomach cancer with hyperexpression of HER2neu includes conducting chemotherapy following the FLOT plan: docetaxel at a dose of 50 mg/m2 by intravenous drop infusion on day 1, oxaliplatin at a dose of 85 mg/m2 by intravenous drop infusion on day 1, with the duration of the infusion of 2 hours, leucovorin at a dose of 200 mg/m2 by intravenous drop infusion on day 1, with the duration of the infusion of 2 hours, 5-fluorouracil 2,600 mg/m2 with an interval between the courses of 14 days, combined with intravenous drop infusion of trastuzumab, and operative treatment. Infusion of 5-fluorouracil is therein conducted for 48 hours. Trastuzumab is introduced at a dose of 4 mg/kg by intravenous drop infusion on day 1 with an additional loading dose of 6 mg/kg. All eight courses of targeted and chemotherapy are conducted prior to operative treatment.
EFFECT: invention improves the results of combined treatment of gastric cancer by eliminating undesirable events of radiation therapy and reducing the frequency of postoperative complications.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBINED TREATMENT OF OPERABLE STOMACH CANCER WITH A POSITIVE PDL STATUS | 2020 |
|
RU2756870C1 |
METHOD FOR COMBINED TREATMENT OF RESECTABLE LOCALLY ADVANCED GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS APPLYING PERSONALISED SYSTEMIC AND INTRAPERITONEAL CHEMOTHERAPY | 2021 |
|
RU2773100C1 |
METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER | 2020 |
|
RU2725079C2 |
METHOD FOR COMBINED TREATMENT OF COLON CANCER | 2023 |
|
RU2820567C1 |
METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED CARDIOESOPHAGEAL CANCER | 2021 |
|
RU2765845C1 |
METHOD FOR COMBINED TREATMENT OF STOMACH CANCER WITH LIMITED PERITONEAL DISSEMINATION | 2021 |
|
RU2763665C2 |
METHOD FOR COMBINED TREATMENT OF SUPEROAMPULAR RECTUM CANCER | 2019 |
|
RU2723599C1 |
METHOD FOR TREATMENT OF PATIENTS WITH GASTRIC CANCER WITH LIMITED PERITONEAL CARCINOMATOSIS | 2021 |
|
RU2769493C2 |
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2461375C1 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
Authors
Dates
2021-12-17—Published
2020-11-17—Filed